During the past decade, Southern California Research LLC conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 14 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern California Research LLC" #1 sponsor was "Sunovion" with 5 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern California Research LLC" #1 collaborator was "Worldwide Clinical Trials" with 2 trials as a collaborator and "Amsterdam UMC, location VUmc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southern California Research LLC" are "Alzheimer Disease" (5 trials), "Binge Eating Disorder" (4 trials), "Depressive Disorder, Major" (4 trials), "Adult Attention Deficit Hyperactivity Disorder" (3 trials) and "Binge-Eating Disorder" (2 trials). Many other conditions were trialed in "Southern California Research LLC" in a lesser frequency.

Most popular intervention types in "Southern California Research LLC" are "Drug" (23 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Dasotraline" (4 trials), "Rapastinel" (4 trials), "Gantenerumab" (2 trials) and "ACT-539313" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern California Research LLC" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Southern California Research LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Southern California Research LLC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Southern California Research LLC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".